X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Reid Porter

Reid Porter is Senior Director of State Public Affairs at the Pharmaceutical Researchers and Manufacturers of America (PhRMA). Reid leads the State Public Affairs team — focusing on supporting biopharmaceutical companies across America and their commitment to combatting the coronavirus health crisis while advancing research and development to meet patients' needs and ensuring that patients can access the medicines they need. Reid double majored in English Literature and Spanish at Middlebury College in Vermont and holds a graduate certificate in Publishing from Columbia University. He enjoys traveling, cheering for the Green Bay Packers, playing and watching soccer, practicing violin, rereading Hemingway novels, and spending time with family.

Recent Posts

Holding pharmacy benefit managers accountable

By Reid Porter  |    February 23, 2023
State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about...   Read More

Stopping pharmacy benefit managers from “gaming the system”

By Reid Porter  |    February 22, 2023
People around the country say they are paying too much for their prescription medicines. State policymakers could help address this problem now. Doing so starts with stopping pharmacy benefit...   Read More

Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines

By Reid Porter  |    January 31, 2023
Middlemen don’t want patients to know how they are stacking the deck against them.   Read More

Patients win as West Virginia implements first-in-nation share the savings policy

By Reid Porter  |    July 8, 2022
West Virginia took a big step towards making insurance work like it should last week. As of July 1, thanks to bipartisan state legislation passed and signed by the Governor in 2021, insurers and...   Read More

Analysis: States can help patients save nearly $1,000 annually on their medicines

By Reid Porter  |    April 21, 2022
According to a new Ipsos/PhRMA poll, most Americans — 82% — agree that lowering out-of-pocket costs for health care should be a top priority for policymakers. A good place to start in lowering these...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."